Molly was a grad student in the Bernt Lab who completed her PhD in 2020. Her scientific interests revolved around how specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML. Molly completed her Postdoctoral Fellowship at Tufts University and is now working in Biotech.